Vigilare Wealth Management - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Vigilare Wealth Management ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$574,000
+1.6%
59,215
+12.6%
0.35%
-13.2%
Q1 2021$565,000
+13.0%
52,580
+54.8%
0.40%
-15.4%
Q4 2020$500,000
+70.1%
33,965
+63.9%
0.47%
+54.9%
Q3 2020$294,000
+39.3%
20,720
-20.6%
0.31%
+43.0%
Q2 2020$211,00026,1000.21%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders